Argenx Se (ARGX) Change in Cash (2015 - 2023)
Argenx Se (ARGX) posted Change in Cash of $488.9 million for Q2 2023, up 364.22% on a QoQ basis from -$185.0 million in Q1 2023, and up 168.45% year-over-year from $182.1 million in Q2 2022.
Argenx Se (ARGX) Change in Cash (2015 - 2023) Analysis & Trends
Argenx Se's Change in Cash history runs 5 years deep, the most recent figure standing at $488.9 million for Q2 2023.
- Quarterly Change in Cash rose 168.45% year-over-year to $488.9 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $19.2 million (up 104.64% YoY) and the FY2025 annual result came in at $1.9 billion, up 265.4% from the prior year.
- Change in Cash was $488.9 million for Q2 2023 at Argenx Se, up from -$185.0 million in the prior quarter.
- Across five years, Change in Cash topped out at $1.2 billion in Q3 2022 and bottomed at -$1.5 billion in Q4 2022.
- A 4-year average of $80.1 million and a median of $105.2 million in 2020 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2021 — Change in Cash plunged 992.91% — and 2022, when it surged 684.14%.
- Argenx Se's Change in Cash stood at $58.8 million in 2020, then sank by 729.43% to -$370.1 million in 2021, then plunged by 298.12% to -$1.5 billion in 2022, then soared by 133.18% to $488.9 million in 2023.
- Business Quant data shows ARGX's Change in Cash at $488.9 million in Q2 2023, -$185.0 million in Q1 2023, and -$1.5 billion in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 243.78 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 57.19 Mn |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 53.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 488.90 Mn |
| Mar 31, 2023 | -185.04 Mn |
| Dec 31, 2022 | -1.47 Bn |
| Sep 30, 2022 | 1.19 Bn |
| Jun 30, 2022 | -714.24 Mn |
| Mar 31, 2022 | 518.66 Mn |
| Dec 31, 2021 | -370.06 Mn |
| Sep 30, 2021 | 151.58 Mn |
| Jun 30, 2021 | -524.97 Mn |
| Mar 31, 2021 | 910.90 Mn |
| Jun 30, 2020 | 58.79 Mn |
| Mar 31, 2020 | 910.90 Mn |
| Dec 31, 2015 | 11.27 Bn |